Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 12 03:20PM ET
7.95
Dollar change
+0.06
Percentage change
0.76
%
Index- P/E- EPS (ttm)-0.39 Insider Own0.03% Shs Outstand0.82M Perf Week5.58%
Market Cap6.52M Forward P/E- EPS next Y-7.60 Insider Trans0.00% Shs Float0.82M Perf Month-9.35%
Income5.72M PEG- EPS next Q-1.42 Inst Own0.17% Short Float1.86% Perf Quarter-17.53%
Sales0.67M P/S9.73 EPS this Y158.20% Inst Trans-99.28% Short Ratio0.34 Perf Half Y-13.59%
Book/sh16.00 P/B0.50 EPS next Y-178.11% ROA-70.37% Short Interest0.02M Perf Year37.54%
Cash/sh4.84 P/C1.64 EPS next 5Y- ROE-85.36% 52W Range5.00 - 27.90 Perf YTD31.40%
Dividend Est.- P/FCF- EPS past 5Y-16.98% ROI43.51% 52W High-71.51% Beta1.74
Dividend TTM- Quick Ratio4.58 Sales past 5Y-14.72% Gross Margin- 52W Low59.00% ATR (14)0.83
Dividend Ex-Date- Current Ratio4.58 EPS Y/Y TTM130.66% Oper. Margin-840.54% RSI (14)44.12 Volatility9.22% 11.23%
Employees23 Debt/Eq0.00 Sales Y/Y TTM-70.05% Profit Margin853.20% Recom2.50 Target Price30.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q53.15% Payout- Rel Volume0.03 Prev Close7.89
Sales Surprise-44.21% EPS Surprise-89.15% Sales Q/Q-81.93% EarningsNov 22 BMO Avg Volume44.42K Price7.95
SMA20-0.68% SMA50-15.68% SMA200-23.28% Trades Volume1,254 Change0.76%
Date Action Analyst Rating Change Price Target Change
Jul-31-24Upgrade H.C. Wainwright Neutral → Buy $30
Nov-22-24 01:00AM
Nov-11-24 01:00AM
Sep-30-24 01:00AM
Sep-19-24 01:00AM
Sep-04-24 01:00AM
01:00AM Loading…
Aug-27-24 01:00AM
Jul-22-24 01:00AM
Jul-15-24 01:00AM
Jul-12-24 01:00AM
Jul-01-24 01:00AM
Jun-06-24 07:52AM
01:00AM
Jun-05-24 01:00AM
May-31-24 01:00AM
May-08-24 01:00AM
07:28AM Loading…
May-06-24 07:28AM
Apr-30-24 07:31AM
Apr-29-24 07:33AM
01:00AM
Apr-19-24 01:00AM
Apr-18-24 06:52AM
01:00AM
Apr-11-24 01:00AM
Apr-03-24 01:00AM
Mar-14-24 02:00AM
Jan-31-24 01:00AM
Jan-09-24 01:00AM
Jan-05-24 01:30AM
Dec-20-23 01:00AM
Dec-14-23 01:00AM
01:21AM Loading…
Nov-29-23 01:21AM
01:00AM
Nov-28-23 01:00AM
Nov-23-23 01:00AM
Nov-14-23 01:00AM
Nov-08-23 01:00AM
Nov-02-23 02:00AM
Oct-20-23 01:00AM
Oct-06-23 04:00PM
Oct-05-23 11:20AM
Sep-20-23 01:00AM
Sep-06-23 01:00AM
Sep-05-23 01:00AM
Sep-04-23 01:00AM
Aug-10-23 01:00AM
Aug-04-23 01:00AM
Aug-03-23 01:00AM
Jul-24-23 01:00AM
Jun-15-23 01:00AM
Jun-01-23 01:00AM
May-18-23 01:00AM
May-11-23 01:00AM
May-10-23 01:00AM
May-05-23 01:00AM
May-04-23 01:00AM
Apr-05-23 01:00AM
Apr-04-23 01:00AM
Apr-03-23 01:00AM
Mar-30-23 01:00AM
Mar-28-23 01:00AM
Mar-16-23 02:00AM
Feb-09-23 01:00AM
Feb-06-23 01:00AM
Jan-19-23 01:00AM
Dec-08-22 01:00AM
Nov-11-22 01:00AM
Nov-03-22 02:00AM
02:00AM
Nov-01-22 02:00AM
Sep-20-22 01:00AM
Aug-18-22 01:00AM
Aug-15-22 01:00AM
Aug-12-22 01:00AM
Jul-26-22 04:00PM
Jul-22-22 01:00AM
Jul-21-22 01:00AM
01:00AM
Jun-17-22 01:00AM
May-27-22 01:00AM
May-19-22 01:00AM
May-13-22 01:00AM
May-10-22 01:00AM
May-05-22 01:00AM
Apr-28-22 01:00AM
Apr-25-22 01:00AM
Apr-13-22 01:00AM
Apr-06-22 01:00AM
Mar-31-22 01:00AM
Mar-29-22 12:00PM
Mar-24-22 02:00AM
Mar-10-22 01:10AM
Mar-07-22 01:00AM
Feb-24-22 01:00AM
Feb-15-22 12:00PM
Feb-03-22 01:00AM
Jan-11-22 01:00AM
Jan-06-22 01:00AM
Dec-17-21 01:00AM
Dec-15-21 01:00AM
Nov-18-21 01:00AM
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.